Rupert Engelhardt

444 total citations
17 papers, 318 citations indexed

About

Rupert Engelhardt is a scholar working on Surgery, Molecular Biology and Hematology. According to data from OpenAlex, Rupert Engelhardt has authored 17 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Molecular Biology and 4 papers in Hematology. Recurrent topics in Rupert Engelhardt's work include Acute Myeloid Leukemia Research (3 papers), Immune Response and Inflammation (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Rupert Engelhardt is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Immune Response and Inflammation (3 papers) and Hematopoietic Stem Cell Transplantation (3 papers). Rupert Engelhardt collaborates with scholars based in Germany, Canada and Japan. Rupert Engelhardt's co-authors include G. W. Löhr, Kiyoshi Yamada, H. Arnold, Chris Galanos, Michael Lübbert, Andréas Mackensen, Ingo Brink, Regina Kunzmann, Claudia I. Müller and Emmanuel Bissé and has published in prestigious journals such as Blood, Biochemical Pharmacology and Cancer Immunology Immunotherapy.

In The Last Decade

Rupert Engelhardt

16 papers receiving 305 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rupert Engelhardt Germany	11	98	81	64	63	57	17	318
MR Halie Netherlands	9	141 1.4×	95 1.2×	82 1.3×	138 2.2×	149 2.6×	17	448
Kory J. Engelke United States	10	93 0.9×	202 2.5×	85 1.3×	106 1.7×	54 0.9×	16	476
R. M. Vigneulle United States	10	72 0.7×	95 1.2×	116 1.8×	187 3.0×	55 1.0×	18	461
Sung‐Hwan Park South Korea	9	99 1.0×	84 1.0×	74 1.2×	27 0.4×	47 0.8×	11	384
Jessica Boklan United States	12	59 0.6×	215 2.7×	118 1.8×	134 2.1×	36 0.6×	30	467
Leszek Kraj Poland	12	47 0.5×	111 1.4×	100 1.6×	36 0.6×	64 1.1×	32	393
D. Shoham Israel	10	191 1.9×	109 1.3×	45 0.7×	106 1.7×	40 0.7×	14	428
Katarzyna Gębura Poland	12	145 1.5×	88 1.1×	66 1.0×	73 1.2×	33 0.6×	22	349
Biljana Jekić Serbia	10	37 0.4×	81 1.0×	51 0.8×	69 1.1×	11 0.2×	42	348
J. L. Chertkov Russia	12	62 0.6×	140 1.7×	54 0.8×	146 2.3×	43 0.8×	37	323

Countries citing papers authored by Rupert Engelhardt

Since Specialization

Citations

This map shows the geographic impact of Rupert Engelhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupert Engelhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupert Engelhardt more than expected).

Fields of papers citing papers by Rupert Engelhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rupert Engelhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupert Engelhardt. The network helps show where Rupert Engelhardt may publish in the future.

Co-authorship network of co-authors of Rupert Engelhardt

This figure shows the co-authorship network connecting the top 25 collaborators of Rupert Engelhardt. A scholar is included among the top collaborators of Rupert Engelhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rupert Engelhardt. Rupert Engelhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Steinhauer, Hjalmar B., et al.. (2015). Iron Status of Dialysis Patients under rhuEPO Therapy. Contributions to nephrology. 87. 78–86.

2.

Weís, Roland, Dietmar Pfeifer, Carmen Scheibenbogen, et al.. (2011). Immune response as a possible mechanism of long-lasting disease control in spontaneous remission of MLL/AF9-positive acute myeloid leukemia. Annals of Hematology. 91(1). 27–32. 20 indexed citations

3.

Engelhardt, Rupert, et al.. (2010). Das Rote Buch. 4 indexed citations

4.

Yamada, Kiyoshi, Ingo Brink, & Rupert Engelhardt. (2005). Factors Influencing [F-18] 2-Fluoro-2-Deoxy-d-Glucose (F-18 FDG) Accumulation in Melanoma Cells: Is FDG a Substrate of Multidrug Resistance (MDR)?. The Journal of Dermatology. 32(5). 335–345. 14 indexed citations

5.

Yamada, Kiyoshi, Ingo Brink, Emmanuel Bissé, Thomas Epting, & Rupert Engelhardt. (2005). Factors Influencing [F-18] 2-Fluoro-2-Deoxy-d-Glucose (F-18 FDG) Uptake in Melanoma Cells: The Role of Proliferation Rate, Viability, Glucose Transporter Expression and Hexokinase Activity. The Journal of Dermatology. 32(5). 316–334. 38 indexed citations

6.

Müller, Claudia I., et al.. (2004). Hematologic and molecular spontaneous remission following sepsis in acute monoblastic leukemia with translocation (9;11): a case report and review of the literature. European Journal Of Haematology. 73(1). 62–66. 31 indexed citations

7.

Müller, Claudia I., Monika Engelhardt, Jörg Laubenberger, et al.. (2002). Myelodysplastic syndrome in transformation to acute myeloid leukemia presenting with diabetes insipidus: due to pituitary infiltration association with abnormalities of chromosomes 3 and 7. European Journal Of Haematology. 69(2). 115–119. 27 indexed citations

8.

Otto, Florian, Peter Stütz, Lothar Färber, et al.. (1997). Downregulation of the Proinflammatory Cytokine Response to Endotoxin by Pretreatment With the Nontoxic Lipid A Analog SDZ MRL 953 in Cancer Patients. Blood. 90(4). 1673–1683. 28 indexed citations

9.

Otto, Florian, Peter Stütz, Lothar Färber, et al.. (1997). Downregulation of the Proinflammatory Cytokine Response to Endotoxin by Pretreatment With the Nontoxic Lipid A Analog SDZ MRL 953 in Cancer Patients. Blood. 90(4). 1673–1683. 28 indexed citations

10.

Otto, Florian, Andréas Mackensen, Roland Mertelsmann, & Rupert Engelhardt. (1995). Complete response of metastatic renal cell carcinoma to low-dose interferon-? treatment. Cancer Immunology Immunotherapy. 40(2). 115–118. 4 indexed citations

11.

Finke, Jürgen & Rupert Engelhardt. (1994). Chemotherapy for Advanced Gastric Cancer. Digestive Surgery. 11(2). 118–120. 3 indexed citations

12.

Mackensen, Andréas, Chris Galanos, & Rupert Engelhardt. (1991). Treatment of Cancer Patients with Endotoxin Induces Release of Endogenous Cytokines. Pathobiology. 59(4). 264–267. 32 indexed citations

13.

Herrmann, Dieter B., et al.. (1989). Treatment of human clonogenic tumor cells and bone marrow progenitor cells with bleomycin and peplomycin under 40.5°C hyperthermia in vitro. European Journal of Cancer and Clinical Oncology. 25(1). 99–104. 1 indexed citations

14.

Yamada, Kiyoshi, et al.. (1989). Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells. Biochemical Pharmacology. 38(13). 2217–2221. 10 indexed citations

15.

Fiebig, Heinz H., et al.. (1985). Effects of cytostatic drugs and 40.5°C hyperthermia on human clonogenic tumor cells. European Journal of Cancer and Clinical Oncology. 21(4). 515–523. 13 indexed citations

16.

Löhr, G. W., H. Arnold, Karl G. Blume, Rupert Engelhardt, & Ernst Beutler. (1973). Hereditary deficiency of glucosephosphate isomerase as a cause of nonspherocytic hemolytic anemia. Annals of Hematology. 26(6). 393–398. 16 indexed citations

17.

Arnold, H., et al.. (1973). Glucosephosphate Isomerase Deficiency: Evidence for In Vivo Instability of an Enzyme Variant With Hemolysis. Blood. 41(5). 691–699. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact